id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
152,,,,,,,,,,,,,,,2024-06-03T11:40:55+06:00,BSH - R170114001,Right,Letrozole,,,"On 25.12.2016 from India, D(Docetaxel 120mg) C(Carbo- 450mg) Herceptin(440mg) with
Peg Support. Completed Maintenance Trastuzumab up to 15.04.2018 > Now on Tamoxifen since June 2018.",2023-01-04,,2024-03-06,,,,,Breast,147,,BSBSC-240000147,MRS. SAMSUN NAHAR,1745850085,1965-08-03,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,3.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,,,,,,,,,,,,,,,,,,,,,,
161,,,,,,,,,,,,,,,2024-06-03T17:09:16+06:00,BSH - R170803069,,Tamoxifen,,,"6 cycle of FAC> 5 Years with Oral Tamoxifen, 4 cycle with Zoledronic acid from 02.10.22 to
03.01.23",2023-02-01,,2023-02-01,,,,,Breast,147,,BSBSC-240000147,MRS. SAMSUN NAHAR,1745850085,1965-08-03,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,,,,,,,,,,,,,,,,,,,,,,
